Dr Mayur Satish Shah

Dr. Mayur Satish Shah is a highly experienced intensivist with international exposure in pulmonary medicine and critical care. He has played a key role in advanced ICU management, organ transplant programs, and sepsis research. Actively involved in teaching, training, and national academic initiatives, he is recognized for his leadership in critical care education and organ donation awareness.

Educational Qualifications

• MD – Medicine
• FNB – Critical Care Medicine
• IDCCM – Indian Diploma in Critical Care Medicine
• PGDCR – Post Graduate Diploma in Clinical Research, Bombay College of Pharmacy
• Specialized training in Lung Transplant Initiation Program – Cleveland Clinic, Ohio
• Certified Trainer – POCUS & Simulation-Based Endoscopic Training

Professional Experience

• Research Fellowship / Observership – Pulmonary Medicine & Critical Care, Cleveland Clinic, Ohio, USA
• Intensivist – Critical Care & Hepatobiliary Diseases, Global Hospitals, Mumbai
• Intensivist – Critical Care, P. D. Hinduja National Hospital & Medical Research Centre, Mumbai
• Consultant – Critical Care Medicine, Nanavati Max Super Speciality Hospital, Mumbai

Professional Memberships

• Indian Society of Critical Care Medicine (ISCCM)
• European Society of Intensive Care Medicine (ESICM)
• European Respiratory Society (ERS)
• American College of Chest Physicians (ACCP)
• American Society for Parenteral and Enteral Nutrition (ASPEN)
• European Society for Clinical Nutrition and Metabolism (ESPEN)
• Association of Medical Consultants (AMC)
• Zonal Organ Transplant Coordination Committee (ZTCC)

Awards & Achievements

• Keynote Speaker on Organ Transplant Awareness at multiple healthcare institutions
• Lead Faculty for workshops on Pediatric Critical Care, Mechanical Ventilation, CRRT & Hemodynamic Monitoring
• Faculty & Guest Speaker at National and International Conferences on Infectious Diseases and Extracorporeal Therapies

Research Papers & Publications

Author:

• Chapter on ‘Ogilvie’s Syndrome, Fulminant Colitis and Toxic Megacolon’ in ‘Textbook of Critical Care,’ 2nd Edition, chapter-55
• Chapter on ‘Monitoring during Continuous Renal Replacement Therapy’ in ISCCM manual of RRT and ECMO in ICU
• Chapter on ‘Cytokine Storm and Immunomodulation’ in ISCCM textbook of critical care medicine, chapter-105

Publications:

• Use of Cytosorb in a case of Salmonella Typhi-Induced Gastroenteritis with Sepsis Associated AKI - Case of The Week 16/2022
• Retrospective Analysis of ExtraCorporeal Filter in Septic Shock - IJCCM, 2022
• Ulinastatin Add-On to Standard Of Care in Critically Ill Covid-19 Patients, a Multicenter Retrospective Study - JAPI 2023 [10.5005/japi-11001-0181]

Research:

• Prospective observational one-centre study for the evaluation of Velimyxin in treating gram-negative MDR bacteria in critically ill
• Prospective, randomised controlled, single-center, two arm (standard control) open-label clinical study to evaluate the efficacy and safety of Thymosin Alpha-1 + Ulinastatin in sepsis patients.
• Clinical correlation of SOFA SCORE, IL-6 and EAA LEVELS in sepsis
• Prospective evaluation of validity of acute renal support index for timing and modality choice of RRT in AKI
• Impact of Respiratory Biofire on Deescalation of Antimicrobial as an Essential Part of AMSP
• Nationwide analysis of ‘Sepsis Registry’